Childhood Leukemia Clinical Trials

6 recruitingLast updated: June 18, 2026

There are 6 actively recruiting childhood leukemia clinical trials across 4 countries. Studies span Phase 3, Phase 2. Top locations include Guiyang, Guizhou, China, Guangzhou, Guangdong, China, Changsha, Hunan, China. Updated daily from ClinicalTrials.gov.


Childhood Leukemia Trials at a Glance

6 actively recruiting trials for childhood leukemia are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Phase 3 with 4 trials, with the heaviest enrollment activity in Guiyang, Guangzhou, and Changsha. Lead sponsors running childhood leukemia studies include Institute of Hematology & Blood Diseases Hospital, China, Australian & New Zealand Children's Haematology/Oncology Group, and Chinese University of Hong Kong.

Browse childhood leukemia trials by phase

Treatments under study

About Childhood Leukemia Clinical Trials

Looking for clinical trials for Childhood Leukemia? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Childhood Leukemia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Childhood Leukemia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting

Advanced Translational Research on Childhood Leukemia

Childhood Leukemia
Chinese University of Hong Kong300 enrolled1 locationNCT04478006
Recruiting
Phase 3

Newly-diagnosed Pediatric Ph-positive B-ALL Protocol

Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+)Childhood Leukemia, Acute Lymphoblastic
Institute of Hematology & Blood Diseases Hospital, China150 enrolled24 locationsNCT07152041
Recruiting
Phase 2Phase 3

Newly-diagnosed Pediatric T-cell ALL Protocol

Acute Lymphoblastic LeukemiaChildhood Leukemia, Acute LymphoblasticT Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
Institute of Hematology & Blood Diseases Hospital, China610 enrolled27 locationsNCT06855810
Recruiting
Phase 2Phase 3

Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol

Childhood Leukemia, Acute LymphoblasticB-cell Acute Lymphoblastic Leukemia (B-ALL)Acute Lymphoblastic Leukemia ALL
Institute of Hematology & Blood Diseases Hospital, China3,000 enrolled27 locationsNCT06882057
Recruiting
Phase 2Phase 3

Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol

Childhood Leukemia, Acute LymphoblasticB-cell Acute Lymphoblastic Leukemia (B-ALL)Acute Lymphoblastic Leukemia ALL
Institute of Hematology & Blood Diseases Hospital, China1,800 enrolled26 locationsNCT06764238
Recruiting

Precision Medicine for Every Child With Cancer

Refractory CancerChildhood CancerChildhood Brain Tumor+3 more
Australian & New Zealand Children's Haematology/Oncology Group3,500 enrolled11 locationsNCT05504772